Status:
TERMINATED
Metabolic Derangements in Acute Heart Failure Syndrome
Lead Sponsor:
The Cleveland Clinic
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
To determine the association of both neurohormonal and hemodynamic alterations associated with metabolic abnormalities in acute heart failure syndrome.
Eligibility Criteria
Inclusion
- Adult (age \> 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.
Exclusion
- History of Congenital Heart Disease.
- Acute HF in the setting of acute myocardial infarction.
- Severe Anemia
- Patients listed for cardiac transplantation.
- Terminal Malignancy, AIDS or CNS disease.
- Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00682175
Start Date
May 1 2008
End Date
March 1 2009
Last Update
March 26 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.